際際滷

際際滷Share a Scribd company logo
HEMIBODY & TOTAL BODY
IRRADIATION
Dr. Dhiman Das
2nd year resident.
Dept. of Radiotherapy
Medical College & Hospital
kolkata
Total Body Irradiation
 TBI is a special radiotherapy technique
that delivers to a patients whole body a
dose uniform to within +/- 10% of the
prescribed dose.
 It is performed as conditioning regime
Journey started only a decade after
discovery of X-ray by German
biophysical engineer Friedrich J.
Dessauer
 In 1907, Alad叩r Elfer,a medical professor in Hungary,
reported his experience using a TBI technique .
 Arthur C. Heublein, in collaboration with Gioacchino
Failla, is credited with the development of the first TBI unit
in North America, located at Memorial Hospital in New
York City.
 In 1959, a kidney was successfully
transplanted between dizygotic twins after TBI
at exposures of up to 450 R.
 In 1957, Nobel laureate E. Donnall Thomas first
reported the use of bone marrow infusion in
humans following whole body irradiation or
chemotherapy, and less than 1 year later he
published his experience in using TBI with
exposures up to 600 R followed by bone
marrow transplantation.
Diseases treated with TBI
 Malignant
 Leukaemia.
 Aplastic anaemia.
 Lymphoma.
 Multiple Myeloma.
 Non Malignant
 Autoimmune
Diseases.
 Inborn errors of
metabolism.
 Aplastic anaemia
Mode of Action
1. Cytotoxicity-Destroy the bone marrow &
tumour cells of the recipient.
2. Immunosuppression-Immunosuppress
the patient sufficiently.
 auto-SCT
 cytotoxicity
 allo-SCT
 cytotoxicity
 immunosuppression
Types of allo-SCT
Myeloablative
a) immunosuppression
b) To create space in bone
marrow for donor cells.
c) To provide further
cytoreduction.
 Example- total dose of 12-
15Gy
Nonmyeloablative
 Mainly a) & b)
 c) to a much lesser degree.
 Example- 2Gy single #
Types of TBI
TOTAL DOSE NO. OF #
1.HIGH DOSE TBI 12Gy 1-6
2.LOW DOSE TBI 10-15cGy/# 10-15
3.TOTAL NODAL
IRRADIATION
40Gy 20
TBI based regime vs Chemotherapy alone
To conclude..
 TBI
 Pros.
 Access to sanctuary sites
 Controllable dose delivery.
 Cons.
 Interstitial pneumonitis.
 Catarct.
 Endocrine deficiency
 Chemotherapy.
 Pros.
 No special arrangements
needed like TBI
 Cons.
 Hepatic VOD/SOS.(BuCy)
 Haemorrhagic
cystitis.(BuCy)
 Seizures.(oral busalphan)
Mode of Delivery
A. Dedicated irradiator.
B. Modified conventional irradiator.
A. Dedicated Irradiators.
1. Treatment at extended SSD.
Hemibody and total body radiation
2.Treatment at standard SSD after the
Co饗collimator is removed.
B.Modified Conventional Irradiator.
1.Treatment with a translational
beam
2.Treatment with a sweeping
beam.
Hemibody and total body radiation
Choice of Technique
 Depends on-
Available equipment
Photon beam energy
Maximum possible field size
Treatment distance
Dose rate
Patient dimension
Choice of Beam Energy
Choice of Portals
1. AP/PA.
o Pros 
a) Better dose uniformity along the longitudinal
body axis.
b) Convenient for treating small children.
o Cons-patient positioning (other than standing
upright) may pose problem.
 Developed in Memorial Sloan Kattering hospital,New
York.
 Shielding (Dusenbery & Gerbi)- Lung,kidney, Brain.
Hemibody and total body radiation
2.Bilateral TBI
 Pros-
 More comfortable to the patient.
 Cons-
 Greater variation in body thickness along the path
of the beam.
Hemibody and total body radiation
Patient
positioning
 Semifetal
position(khan et
al.)
 Arms are
positioned
laterally to follow
the body contour.
 Arms should
shadow the lungs,
not the Spinal
Column.
 Pt set-up.
 SAD
 Compensators
are designed for
H&N ,lungs,legs.
 Reference
thickness for
compensator is
the lateral
diameter of the
body at the level
Compensator Design
 Challenges 
 Large variation in body thickness.
 Lack of complete body immobilisation.
 Internal tissue heterogeneities.
Compensator Thickness along a ray
line
a) Tissue deficit, compared to the reference
depth at the prescription point.
b) Material(density).
c) Distance from the point of compensation.
d) Depth of the point of compensation.
e) Field size.
f) Beam energy.
Thickness Ratio()
 The required thickness of a tissue equivalent
compensator that gives the same dose at the
point of interest as would a bolus of thickness
equal to the tissue deficit.
 For TBI an average value of 0.7 provides good
approximation of all beam energies &
compensation conditions.
Formulae to obtain compensator
thickness
1.
 Tc=comp thickness
 TD=tissue deficit
 痢c=density of comp
2.
 I/I魅=doses before & after
comp added.
 T(A甦d甦) &T(A d)=TPR for
ref body section & sectn
to be compensated.
Hemibody and total body radiation
Dosimetry
A.Directly
 By using a 0.6cm甬 Farmer-
type ionisation chamber
placed in a 40cm甬 water
phantom.
 By placing TLD
capsule/chips in strategic
locations in body.(in-vivo
dosimetry)
B.Indirectly
 By using this formula.
Adverse effects
In nonmyeloablative regimen
Acute
Nausea
Vomiting
Long term
cataract
Adverse effects
In myeloablative regimens
Acute
 Nausea, Vomiting
 mucositis
 Diarrhoea
 Xerostomia
 Headache
 Fever
 HTN
 Reversible alopecia
 Parotiditis
Long-term
 Lung-interstitial
pneumonitis.
 Lens-cataract.
 Growth & gonadal &
Endocrine effects.
 Liver-VOD & SOS
 Kidney.
 2属 cancers.
HEMI BODY IRRADIATION
 INDICATIONS-
 To alleviate symptoms in metastatic diseases.
 Delaying progression of existing
asymptomatic mets.
 Defers development of new mets.
Difference with TBI
 Different therapeutic goal.
 Smaller field size.
 Lesser side effects
Technique
 Bottom of L4 separates uper & lower half.
 A/P parallal opposed fields.
 Patients positioned with vertical beam
allowing coverage of hemibody.
 Necessary shielding.
 Dose prescribed to mid-plane of the
patient at the central axis of the beam.
Dose
 Upper HBI-6Gy
 Lower HBI-8Gy
Rx for other half
 Wait for 6-8 weeks.
Side effects
Nausea ,vomiting(M/C)
Fatigue.
Cough, breathlessness.
Interstitial pneumonitis.
Reversible alopecia
Dry mouth, stomatitis.
Parotid swelling.
Hemibody and total body radiation

More Related Content

What's hot (20)

Proton beam therapy
Proton beam therapyProton beam therapy
Proton beam therapy
Nanditha Nukala
Total body irradiation
Total body irradiationTotal body irradiation
Total body irradiation
Kiran Ramakrishna
TIME DOSE & FRACTIONATION
TIME DOSE & FRACTIONATIONTIME DOSE & FRACTIONATION
TIME DOSE & FRACTIONATION
Isha Jaiswal
Carbon ion therapy
Carbon ion therapyCarbon ion therapy
Carbon ion therapy
umesh V
Brachytherapy dosimetry systems .R
Brachytherapy dosimetry systems .RBrachytherapy dosimetry systems .R
Brachytherapy dosimetry systems .R
raazvarma
ICRU CONCEPT
ICRU CONCEPTICRU CONCEPT
ICRU CONCEPT
Kanhu Charan
Rrecent advances in linear accelerators [MR linac]
Rrecent advances in linear accelerators [MR linac]Rrecent advances in linear accelerators [MR linac]
Rrecent advances in linear accelerators [MR linac]
Upasna Saxena
Image Guided Radiation Therapy (IGRT)
Image Guided Radiation Therapy (IGRT)Image Guided Radiation Therapy (IGRT)
Image Guided Radiation Therapy (IGRT)
Teekendra Singh Faujdar
Plan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr KiranPlan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr Kiran
Kiran Ramakrishna
Interstitial BT Principles
Interstitial BT PrinciplesInterstitial BT Principles
Interstitial BT Principles
Yamini Baviskar
Treatment plannings i kiran
Treatment plannings i   kiranTreatment plannings i   kiran
Treatment plannings i kiran
Kiran Ramakrishna
BASICS RADIOBIOLOGY FOR RADIOTHERAPY
BASICS RADIOBIOLOGY FOR RADIOTHERAPYBASICS RADIOBIOLOGY FOR RADIOTHERAPY
BASICS RADIOBIOLOGY FOR RADIOTHERAPY
Nik Noor Ashikin Nik Ab Razak
ICRU 38 nayana
ICRU 38 nayanaICRU 38 nayana
ICRU 38 nayana
NAYANA KRISHNAN
Role of SBRT in lung cancer
Role of SBRT in lung cancerRole of SBRT in lung cancer
Role of SBRT in lung cancer
DrAyush Garg
Icru 50,62,83 volume deliniation
Icru 50,62,83 volume deliniationIcru 50,62,83 volume deliniation
Icru 50,62,83 volume deliniation
althaf jouhar
Stereotactic Body Radiation Therapy
Stereotactic Body Radiation TherapyStereotactic Body Radiation Therapy
Stereotactic Body Radiation Therapy
fondas vakalis
physics and clinical aspects of interstitial brachytherapy
physics and clinical aspects of interstitial brachytherapyphysics and clinical aspects of interstitial brachytherapy
physics and clinical aspects of interstitial brachytherapy
VIMOJ JANARDANAN NAIR
Image Guided Radiotherapy
Image Guided RadiotherapyImage Guided Radiotherapy
Image Guided Radiotherapy
Sheetal R Kashid
Fractionated radiation and dose rate effect
Fractionated radiation and dose rate effectFractionated radiation and dose rate effect
Fractionated radiation and dose rate effect
Parag Roy
COMPLETE OVERVIEW ON ADAPTIVE RADIOTHERAPY OVER DAILY IMAGE GUIDED RADIOTHERAPY
COMPLETE OVERVIEW ON ADAPTIVE RADIOTHERAPY OVER DAILY IMAGE GUIDED RADIOTHERAPYCOMPLETE OVERVIEW ON ADAPTIVE RADIOTHERAPY OVER DAILY IMAGE GUIDED RADIOTHERAPY
COMPLETE OVERVIEW ON ADAPTIVE RADIOTHERAPY OVER DAILY IMAGE GUIDED RADIOTHERAPY
Subrata Roy
TIME DOSE & FRACTIONATION
TIME DOSE & FRACTIONATIONTIME DOSE & FRACTIONATION
TIME DOSE & FRACTIONATION
Isha Jaiswal
Carbon ion therapy
Carbon ion therapyCarbon ion therapy
Carbon ion therapy
umesh V
Brachytherapy dosimetry systems .R
Brachytherapy dosimetry systems .RBrachytherapy dosimetry systems .R
Brachytherapy dosimetry systems .R
raazvarma
Rrecent advances in linear accelerators [MR linac]
Rrecent advances in linear accelerators [MR linac]Rrecent advances in linear accelerators [MR linac]
Rrecent advances in linear accelerators [MR linac]
Upasna Saxena
Image Guided Radiation Therapy (IGRT)
Image Guided Radiation Therapy (IGRT)Image Guided Radiation Therapy (IGRT)
Image Guided Radiation Therapy (IGRT)
Teekendra Singh Faujdar
Plan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr KiranPlan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr Kiran
Kiran Ramakrishna
Interstitial BT Principles
Interstitial BT PrinciplesInterstitial BT Principles
Interstitial BT Principles
Yamini Baviskar
Treatment plannings i kiran
Treatment plannings i   kiranTreatment plannings i   kiran
Treatment plannings i kiran
Kiran Ramakrishna
Role of SBRT in lung cancer
Role of SBRT in lung cancerRole of SBRT in lung cancer
Role of SBRT in lung cancer
DrAyush Garg
Icru 50,62,83 volume deliniation
Icru 50,62,83 volume deliniationIcru 50,62,83 volume deliniation
Icru 50,62,83 volume deliniation
althaf jouhar
Stereotactic Body Radiation Therapy
Stereotactic Body Radiation TherapyStereotactic Body Radiation Therapy
Stereotactic Body Radiation Therapy
fondas vakalis
physics and clinical aspects of interstitial brachytherapy
physics and clinical aspects of interstitial brachytherapyphysics and clinical aspects of interstitial brachytherapy
physics and clinical aspects of interstitial brachytherapy
VIMOJ JANARDANAN NAIR
Image Guided Radiotherapy
Image Guided RadiotherapyImage Guided Radiotherapy
Image Guided Radiotherapy
Sheetal R Kashid
Fractionated radiation and dose rate effect
Fractionated radiation and dose rate effectFractionated radiation and dose rate effect
Fractionated radiation and dose rate effect
Parag Roy
COMPLETE OVERVIEW ON ADAPTIVE RADIOTHERAPY OVER DAILY IMAGE GUIDED RADIOTHERAPY
COMPLETE OVERVIEW ON ADAPTIVE RADIOTHERAPY OVER DAILY IMAGE GUIDED RADIOTHERAPYCOMPLETE OVERVIEW ON ADAPTIVE RADIOTHERAPY OVER DAILY IMAGE GUIDED RADIOTHERAPY
COMPLETE OVERVIEW ON ADAPTIVE RADIOTHERAPY OVER DAILY IMAGE GUIDED RADIOTHERAPY
Subrata Roy

Similar to Hemibody and total body radiation (20)

TBI.pptx total body irradiation radiotherapy
TBI.pptx total body irradiation radiotherapyTBI.pptx total body irradiation radiotherapy
TBI.pptx total body irradiation radiotherapy
dranjalikrishnanp
Total body irradiation
Total body irradiationTotal body irradiation
Total body irradiation
Bharat Mistary
TBI.ppT . DR ANJALIKRISHNA , PG RESIDENT AIIMS GKP
TBI.ppT . DR ANJALIKRISHNA , PG RESIDENT AIIMS GKPTBI.ppT . DR ANJALIKRISHNA , PG RESIDENT AIIMS GKP
TBI.ppT . DR ANJALIKRISHNA , PG RESIDENT AIIMS GKP
dranjalikrishnanp
TBI
TBITBI
TBI
Aparna Attoor
Time dose & fractionation relationship
Time dose & fractionation relationship Time dose & fractionation relationship
Time dose & fractionation relationship
Amin Amin
Re Radiation
Re RadiationRe Radiation
Re Radiation
Dr.Rashmi Yadav
Radiotherapy in ENT
Radiotherapy in ENTRadiotherapy in ENT
Radiotherapy in ENT
Yousuf Choudhury
1.radiation of h&n tumors
1.radiation of h&n tumors1.radiation of h&n tumors
1.radiation of h&n tumors
www.ffofr.org - Foundation for Oral Facial Rehabilitiation
Particle beam proton,neutron & heavy ion therapy
Particle beam  proton,neutron & heavy ion therapyParticle beam  proton,neutron & heavy ion therapy
Particle beam proton,neutron & heavy ion therapy
Aswathi c p
ICRU 83
ICRU 83ICRU 83
ICRU 83
apollo seminar group
Understanding Radiation Units and Quantities, MDIRT Nchanji Nkeh Keneth
Understanding Radiation Units and Quantities, MDIRT Nchanji Nkeh KenethUnderstanding Radiation Units and Quantities, MDIRT Nchanji Nkeh Keneth
Understanding Radiation Units and Quantities, MDIRT Nchanji Nkeh Keneth
Nchanji Nkeh Keneth
Radiotherapy In Early Breast Cancer
Radiotherapy In Early Breast CancerRadiotherapy In Early Breast Cancer
Radiotherapy In Early Breast Cancer
Dr.T.Sujit :-)
Time dose fractionation IN Radiobiology.pptx
Time dose fractionation IN Radiobiology.pptxTime dose fractionation IN Radiobiology.pptx
Time dose fractionation IN Radiobiology.pptx
vijayshree231
INTRA OPERATIVE RADIOTHERAPY-DR ANDREA R SALINS
INTRA OPERATIVE RADIOTHERAPY-DR ANDREA R SALINSINTRA OPERATIVE RADIOTHERAPY-DR ANDREA R SALINS
INTRA OPERATIVE RADIOTHERAPY-DR ANDREA R SALINS
Dr Andrea R Salins
Therapeutic nuclear medicine
Therapeutic nuclear medicineTherapeutic nuclear medicine
Therapeutic nuclear medicine
Sabari Kumar
Medical uses of ionising radiation
Medical uses of ionising radiationMedical uses of ionising radiation
Medical uses of ionising radiation
Amin Amin
Radiobiologia aplicada a f鱈sica m辿dica e suas aplica巽探es
Radiobiologia aplicada a f鱈sica m辿dica e suas aplica巽探esRadiobiologia aplicada a f鱈sica m辿dica e suas aplica巽探es
Radiobiologia aplicada a f鱈sica m辿dica e suas aplica巽探es
larachavest3
Rad Physics Radiation Quantities and Units.ppt
Rad Physics Radiation Quantities and Units.pptRad Physics Radiation Quantities and Units.ppt
Rad Physics Radiation Quantities and Units.ppt
Liwi Martin Odey
patient dose management in angiography king saud unversity.pdf
patient dose management in angiography king saud unversity.pdfpatient dose management in angiography king saud unversity.pdf
patient dose management in angiography king saud unversity.pdf
naima SENHOU
FACTORS AFFECTING PATIENT DOSE IN RADIOLOGICAL EXAMINATIONS.pptx
FACTORS AFFECTING PATIENT DOSE IN RADIOLOGICAL EXAMINATIONS.pptxFACTORS AFFECTING PATIENT DOSE IN RADIOLOGICAL EXAMINATIONS.pptx
FACTORS AFFECTING PATIENT DOSE IN RADIOLOGICAL EXAMINATIONS.pptx
Nomeh Henry
TBI.pptx total body irradiation radiotherapy
TBI.pptx total body irradiation radiotherapyTBI.pptx total body irradiation radiotherapy
TBI.pptx total body irradiation radiotherapy
dranjalikrishnanp
Total body irradiation
Total body irradiationTotal body irradiation
Total body irradiation
Bharat Mistary
TBI.ppT . DR ANJALIKRISHNA , PG RESIDENT AIIMS GKP
TBI.ppT . DR ANJALIKRISHNA , PG RESIDENT AIIMS GKPTBI.ppT . DR ANJALIKRISHNA , PG RESIDENT AIIMS GKP
TBI.ppT . DR ANJALIKRISHNA , PG RESIDENT AIIMS GKP
dranjalikrishnanp
Time dose & fractionation relationship
Time dose & fractionation relationship Time dose & fractionation relationship
Time dose & fractionation relationship
Amin Amin
Particle beam proton,neutron & heavy ion therapy
Particle beam  proton,neutron & heavy ion therapyParticle beam  proton,neutron & heavy ion therapy
Particle beam proton,neutron & heavy ion therapy
Aswathi c p
Understanding Radiation Units and Quantities, MDIRT Nchanji Nkeh Keneth
Understanding Radiation Units and Quantities, MDIRT Nchanji Nkeh KenethUnderstanding Radiation Units and Quantities, MDIRT Nchanji Nkeh Keneth
Understanding Radiation Units and Quantities, MDIRT Nchanji Nkeh Keneth
Nchanji Nkeh Keneth
Radiotherapy In Early Breast Cancer
Radiotherapy In Early Breast CancerRadiotherapy In Early Breast Cancer
Radiotherapy In Early Breast Cancer
Dr.T.Sujit :-)
Time dose fractionation IN Radiobiology.pptx
Time dose fractionation IN Radiobiology.pptxTime dose fractionation IN Radiobiology.pptx
Time dose fractionation IN Radiobiology.pptx
vijayshree231
INTRA OPERATIVE RADIOTHERAPY-DR ANDREA R SALINS
INTRA OPERATIVE RADIOTHERAPY-DR ANDREA R SALINSINTRA OPERATIVE RADIOTHERAPY-DR ANDREA R SALINS
INTRA OPERATIVE RADIOTHERAPY-DR ANDREA R SALINS
Dr Andrea R Salins
Therapeutic nuclear medicine
Therapeutic nuclear medicineTherapeutic nuclear medicine
Therapeutic nuclear medicine
Sabari Kumar
Medical uses of ionising radiation
Medical uses of ionising radiationMedical uses of ionising radiation
Medical uses of ionising radiation
Amin Amin
Radiobiologia aplicada a f鱈sica m辿dica e suas aplica巽探es
Radiobiologia aplicada a f鱈sica m辿dica e suas aplica巽探esRadiobiologia aplicada a f鱈sica m辿dica e suas aplica巽探es
Radiobiologia aplicada a f鱈sica m辿dica e suas aplica巽探es
larachavest3
Rad Physics Radiation Quantities and Units.ppt
Rad Physics Radiation Quantities and Units.pptRad Physics Radiation Quantities and Units.ppt
Rad Physics Radiation Quantities and Units.ppt
Liwi Martin Odey
patient dose management in angiography king saud unversity.pdf
patient dose management in angiography king saud unversity.pdfpatient dose management in angiography king saud unversity.pdf
patient dose management in angiography king saud unversity.pdf
naima SENHOU
FACTORS AFFECTING PATIENT DOSE IN RADIOLOGICAL EXAMINATIONS.pptx
FACTORS AFFECTING PATIENT DOSE IN RADIOLOGICAL EXAMINATIONS.pptxFACTORS AFFECTING PATIENT DOSE IN RADIOLOGICAL EXAMINATIONS.pptx
FACTORS AFFECTING PATIENT DOSE IN RADIOLOGICAL EXAMINATIONS.pptx
Nomeh Henry

Recently uploaded (20)

One Health Rabies Control in Indonesia_APCAT meeting May 2022.pptx
One Health Rabies Control in Indonesia_APCAT meeting May 2022.pptxOne Health Rabies Control in Indonesia_APCAT meeting May 2022.pptx
One Health Rabies Control in Indonesia_APCAT meeting May 2022.pptx
Wahid Husein
IMMUNO-ONCOLOGY DESCOVERING THE IMPORTANCE OF CLINICAL IMUNOLOGY IN MEDICINE
IMMUNO-ONCOLOGY  DESCOVERING THE IMPORTANCE OF CLINICAL IMUNOLOGY IN MEDICINEIMMUNO-ONCOLOGY  DESCOVERING THE IMPORTANCE OF CLINICAL IMUNOLOGY IN MEDICINE
IMMUNO-ONCOLOGY DESCOVERING THE IMPORTANCE OF CLINICAL IMUNOLOGY IN MEDICINE
RelianceNwosu
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
zilkerapurbo
Local Anesthetic Use in the Vulnerable Patients
Local Anesthetic Use in the Vulnerable PatientsLocal Anesthetic Use in the Vulnerable Patients
Local Anesthetic Use in the Vulnerable Patients
Reza Aminnejad
Details Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & AyurvedaDetails Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & Ayurveda
RaviAnand201252
MLS 208 - UNIT 1- Lecture Notes - ETANDO AYUK - SANU - Secured.pdf
MLS 208 -  UNIT 1-  Lecture Notes - ETANDO AYUK - SANU - Secured.pdfMLS 208 -  UNIT 1-  Lecture Notes - ETANDO AYUK - SANU - Secured.pdf
MLS 208 - UNIT 1- Lecture Notes - ETANDO AYUK - SANU - Secured.pdf
Eswatini Medical Christian University - EMCU / Southern Nazarene University - SANU
The influence of birth companion in mother care and neonatal outcome
The influence of birth companion in mother care and neonatal outcomeThe influence of birth companion in mother care and neonatal outcome
The influence of birth companion in mother care and neonatal outcome
Lokesh Kumar Sharma
Non-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for NeurosurgeonsNon-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for Neurosurgeons
Dhaval Shukla
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptxRabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Wahid Husein
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptxPRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
karishmaduhijod1
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Ganapathi Vankudoth
Biography of Dr. Vincenzo Giordano
Biography of Dr. Vincenzo GiordanoBiography of Dr. Vincenzo Giordano
Biography of Dr. Vincenzo Giordano
Dr. Vincenzo Giordano
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
maheenmazhar021
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
HER2-Targeting Therapy in HER2+ MBC With and Without CNS Metastases: Selectio...
PVI, PeerView Institute for Medical Education
4-PuroKalusugasan 2025 DM 2025-0024.pptx
4-PuroKalusugasan 2025 DM 2025-0024.pptx4-PuroKalusugasan 2025 DM 2025-0024.pptx
4-PuroKalusugasan 2025 DM 2025-0024.pptx
NashiedaLilangBuale
Hemoblastosis lecture by pathological anatomy
Hemoblastosis lecture by pathological anatomyHemoblastosis lecture by pathological anatomy
Hemoblastosis lecture by pathological anatomy
26d78y5bwr
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLEHUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
daminipatel37
Stability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH GuidelinesStability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH Guidelines
KHUSHAL CHAVAN
legal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptxlegal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptx
Rishika Rawat
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptxphysiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
amralmohammady27
One Health Rabies Control in Indonesia_APCAT meeting May 2022.pptx
One Health Rabies Control in Indonesia_APCAT meeting May 2022.pptxOne Health Rabies Control in Indonesia_APCAT meeting May 2022.pptx
One Health Rabies Control in Indonesia_APCAT meeting May 2022.pptx
Wahid Husein
IMMUNO-ONCOLOGY DESCOVERING THE IMPORTANCE OF CLINICAL IMUNOLOGY IN MEDICINE
IMMUNO-ONCOLOGY  DESCOVERING THE IMPORTANCE OF CLINICAL IMUNOLOGY IN MEDICINEIMMUNO-ONCOLOGY  DESCOVERING THE IMPORTANCE OF CLINICAL IMUNOLOGY IN MEDICINE
IMMUNO-ONCOLOGY DESCOVERING THE IMPORTANCE OF CLINICAL IMUNOLOGY IN MEDICINE
RelianceNwosu
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
Correlation of vitamin D level with prediabetes status_Dr Ahmed Al Montasir_f...
zilkerapurbo
Local Anesthetic Use in the Vulnerable Patients
Local Anesthetic Use in the Vulnerable PatientsLocal Anesthetic Use in the Vulnerable Patients
Local Anesthetic Use in the Vulnerable Patients
Reza Aminnejad
Details Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & AyurvedaDetails Study of Haemorrhage Modern & Ayurveda
Details Study of Haemorrhage Modern & Ayurveda
RaviAnand201252
The influence of birth companion in mother care and neonatal outcome
The influence of birth companion in mother care and neonatal outcomeThe influence of birth companion in mother care and neonatal outcome
The influence of birth companion in mother care and neonatal outcome
Lokesh Kumar Sharma
Non-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for NeurosurgeonsNon-Invasive ICP Monitoring for Neurosurgeons
Non-Invasive ICP Monitoring for Neurosurgeons
Dhaval Shukla
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptxRabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Rabies Bali 2008-2020_WRD Webinar_WSAVA 2020_Final.pptx
Wahid Husein
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptxPRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
PRODUCTION OF HB VACCINE AND INTERFERONS BY rDNA - Copy.pptx
karishmaduhijod1
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Acute & Chronic Inflammation, Chemical mediators in Inflammation and Wound he...
Ganapathi Vankudoth
Biography of Dr. Vincenzo Giordano
Biography of Dr. Vincenzo GiordanoBiography of Dr. Vincenzo Giordano
Biography of Dr. Vincenzo Giordano
Dr. Vincenzo Giordano
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....MORPHOLOGICAL FEATURES OF PNEUMONIA.....
MORPHOLOGICAL FEATURES OF PNEUMONIA.....
maheenmazhar021
4-PuroKalusugasan 2025 DM 2025-0024.pptx
4-PuroKalusugasan 2025 DM 2025-0024.pptx4-PuroKalusugasan 2025 DM 2025-0024.pptx
4-PuroKalusugasan 2025 DM 2025-0024.pptx
NashiedaLilangBuale
Hemoblastosis lecture by pathological anatomy
Hemoblastosis lecture by pathological anatomyHemoblastosis lecture by pathological anatomy
Hemoblastosis lecture by pathological anatomy
26d78y5bwr
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLEHUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
HUMAN SEXUALITY AND SEXUAL RESPONCE CYCLE
daminipatel37
Stability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH GuidelinesStability of Dosage Forms as per ICH Guidelines
Stability of Dosage Forms as per ICH Guidelines
KHUSHAL CHAVAN
legal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptxlegal Rights of individual, children and women.pptx
legal Rights of individual, children and women.pptx
Rishika Rawat
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptxphysiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
physiology 1 T3T4 & Jaundice & capillary circulation 愕悗悋.pptx
amralmohammady27

Hemibody and total body radiation

  • 1. HEMIBODY & TOTAL BODY IRRADIATION Dr. Dhiman Das 2nd year resident. Dept. of Radiotherapy Medical College & Hospital kolkata
  • 2. Total Body Irradiation TBI is a special radiotherapy technique that delivers to a patients whole body a dose uniform to within +/- 10% of the prescribed dose. It is performed as conditioning regime
  • 3. Journey started only a decade after discovery of X-ray by German biophysical engineer Friedrich J. Dessauer
  • 4. In 1907, Alad叩r Elfer,a medical professor in Hungary, reported his experience using a TBI technique . Arthur C. Heublein, in collaboration with Gioacchino Failla, is credited with the development of the first TBI unit in North America, located at Memorial Hospital in New York City.
  • 5. In 1959, a kidney was successfully transplanted between dizygotic twins after TBI at exposures of up to 450 R. In 1957, Nobel laureate E. Donnall Thomas first reported the use of bone marrow infusion in humans following whole body irradiation or chemotherapy, and less than 1 year later he published his experience in using TBI with exposures up to 600 R followed by bone marrow transplantation.
  • 6. Diseases treated with TBI Malignant Leukaemia. Aplastic anaemia. Lymphoma. Multiple Myeloma. Non Malignant Autoimmune Diseases. Inborn errors of metabolism. Aplastic anaemia
  • 7. Mode of Action 1. Cytotoxicity-Destroy the bone marrow & tumour cells of the recipient. 2. Immunosuppression-Immunosuppress the patient sufficiently.
  • 8. auto-SCT cytotoxicity allo-SCT cytotoxicity immunosuppression
  • 9. Types of allo-SCT Myeloablative a) immunosuppression b) To create space in bone marrow for donor cells. c) To provide further cytoreduction. Example- total dose of 12- 15Gy Nonmyeloablative Mainly a) & b) c) to a much lesser degree. Example- 2Gy single #
  • 10. Types of TBI TOTAL DOSE NO. OF # 1.HIGH DOSE TBI 12Gy 1-6 2.LOW DOSE TBI 10-15cGy/# 10-15 3.TOTAL NODAL IRRADIATION 40Gy 20
  • 11. TBI based regime vs Chemotherapy alone
  • 12. To conclude.. TBI Pros. Access to sanctuary sites Controllable dose delivery. Cons. Interstitial pneumonitis. Catarct. Endocrine deficiency Chemotherapy. Pros. No special arrangements needed like TBI Cons. Hepatic VOD/SOS.(BuCy) Haemorrhagic cystitis.(BuCy) Seizures.(oral busalphan)
  • 13. Mode of Delivery A. Dedicated irradiator. B. Modified conventional irradiator.
  • 14. A. Dedicated Irradiators. 1. Treatment at extended SSD.
  • 16. 2.Treatment at standard SSD after the Co饗collimator is removed.
  • 18. 2.Treatment with a sweeping beam.
  • 20. Choice of Technique Depends on- Available equipment Photon beam energy Maximum possible field size Treatment distance Dose rate Patient dimension
  • 21. Choice of Beam Energy
  • 22. Choice of Portals 1. AP/PA. o Pros a) Better dose uniformity along the longitudinal body axis. b) Convenient for treating small children. o Cons-patient positioning (other than standing upright) may pose problem. Developed in Memorial Sloan Kattering hospital,New York. Shielding (Dusenbery & Gerbi)- Lung,kidney, Brain.
  • 24. 2.Bilateral TBI Pros- More comfortable to the patient. Cons- Greater variation in body thickness along the path of the beam.
  • 26. Patient positioning Semifetal position(khan et al.) Arms are positioned laterally to follow the body contour. Arms should shadow the lungs, not the Spinal Column. Pt set-up. SAD
  • 27. Compensators are designed for H&N ,lungs,legs. Reference thickness for compensator is the lateral diameter of the body at the level
  • 28. Compensator Design Challenges Large variation in body thickness. Lack of complete body immobilisation. Internal tissue heterogeneities.
  • 29. Compensator Thickness along a ray line a) Tissue deficit, compared to the reference depth at the prescription point. b) Material(density). c) Distance from the point of compensation. d) Depth of the point of compensation. e) Field size. f) Beam energy.
  • 30. Thickness Ratio() The required thickness of a tissue equivalent compensator that gives the same dose at the point of interest as would a bolus of thickness equal to the tissue deficit. For TBI an average value of 0.7 provides good approximation of all beam energies & compensation conditions.
  • 31. Formulae to obtain compensator thickness 1. Tc=comp thickness TD=tissue deficit 痢c=density of comp 2. I/I魅=doses before & after comp added. T(A甦d甦) &T(A d)=TPR for ref body section & sectn to be compensated.
  • 33. Dosimetry A.Directly By using a 0.6cm甬 Farmer- type ionisation chamber placed in a 40cm甬 water phantom. By placing TLD capsule/chips in strategic locations in body.(in-vivo dosimetry) B.Indirectly By using this formula.
  • 34. Adverse effects In nonmyeloablative regimen Acute Nausea Vomiting Long term cataract
  • 35. Adverse effects In myeloablative regimens Acute Nausea, Vomiting mucositis Diarrhoea Xerostomia Headache Fever HTN Reversible alopecia Parotiditis Long-term Lung-interstitial pneumonitis. Lens-cataract. Growth & gonadal & Endocrine effects. Liver-VOD & SOS Kidney. 2属 cancers.
  • 36. HEMI BODY IRRADIATION INDICATIONS- To alleviate symptoms in metastatic diseases. Delaying progression of existing asymptomatic mets. Defers development of new mets.
  • 37. Difference with TBI Different therapeutic goal. Smaller field size. Lesser side effects
  • 38. Technique Bottom of L4 separates uper & lower half. A/P parallal opposed fields. Patients positioned with vertical beam allowing coverage of hemibody. Necessary shielding. Dose prescribed to mid-plane of the patient at the central axis of the beam.
  • 39. Dose Upper HBI-6Gy Lower HBI-8Gy Rx for other half Wait for 6-8 weeks.
  • 40. Side effects Nausea ,vomiting(M/C) Fatigue. Cough, breathlessness. Interstitial pneumonitis. Reversible alopecia Dry mouth, stomatitis. Parotid swelling.